News
Cancer patients receiving ICIs may experience more severe toxicity and have a greater risk of death if they have recently used PPIs, data suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback